| The protein kinase CK2 facilitates repair of chromosomal DNA single-strand breaks JI Loizou, SF El-Khamisy, A Zlatanou, DJ Moore, DW Chan, J Qin, ... Cell 117 (1), 17-28, 2004 | 372 | 2004 |
| A cell cycle-specific requirement for the XRCC1 BRCT II domain during mammalian DNA strand break repair RM Taylor, DJ Moore, J Whitehouse, P Johnson, KW Caldecott Molecular and cellular biology, 2000 | 156 | 2000 |
| Phenotypic anchoring of gene expression changes during estrogen-induced uterine growth JG Moggs, H Tinwell, T Spurway, HS Chang, I Pate, FL Lim, DJ Moore, ... Environmental health perspectives 112 (16), 1589-1606, 2004 | 154 | 2004 |
| Linking Molecular and Population Stress Responses in Daphnia magna exposed to cadmium R Connon, HL Hooper, RM Sibly, FL Lim, LH Heckmann, DJ Moore, ... Environmental science & technology 42 (6), 2181-2188, 2008 | 135 | 2008 |
| Anti-proliferative effect of estrogen in breast cancer cells that re-express ERα is mediated by aberrant regulation of cell cycle genes JG Moggs, TC Murphy, FL Lim, DJ Moore, R Stuckey, K Antrobus, ... Journal of molecular endocrinology 34 (2), 535-551, 2005 | 102 | 2005 |
| Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent … RA Currie, V Bombail, JD Oliver, DJ Moore, FL Lim, V Gwilliam, I Kimber, ... Toxicological Sciences 86 (2), 453-469, 2005 | 86 | 2005 |
| Optimisation of circulating biomarkers of cell death for routine clinical use A Greystoke, J Cummings, T Ward, K Simpson, A Renehan, F Butt, ... Annals of oncology 19 (5), 990-995, 2008 | 85 | 2008 |
| Mutation of a BRCT domain selectively disrupts DNA single-strand break repair in noncycling Chinese hamster ovary cells DJ Moore, RM Taylor, P Clements, KW Caldecott Proceedings of the National Academy of Sciences 97 (25), 13649-13654, 2000 | 77 | 2000 |
| The need to decide if all estrogens are intrinsically similar JG Moggs, J Ashby, H Tinwell, FL Lim, DJ Moore, I Kimber, G Orphanides Environmental Health Perspectives 112 (11), 1137-1142, 2004 | 73 | 2004 |
| AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer–results of two parallel first-in-human phase I studies A Omlin, RJ Jones, R Van Der Noll, T Satoh, M Niwakawa, SA Smith, ... Investigational new drugs 33, 679-690, 2015 | 55 | 2015 |
| Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma J Cummings, M Ranson, F Butt, D Moore, C Dive Cancer chemotherapy and pharmacology 60, 921-924, 2007 | 47 | 2007 |
| Quantification of skeletal metastases in castrate‐resistant prostate cancer predicts progression‐free and overall survival C Tait, D Moore, C Hodgson, M Brown, T Morris, J Growcott, M Malone, ... BJU international 114 (6b), E70-E73, 2014 | 39 | 2014 |
| A pilot study assessing the prognostic value of CK18 and nDNA biomarkers in severe sepsis patients DJ Moore, A Greystoke, F Butt, J Wurthner, J Growcott, A Hughes, C Dive Clinical drug investigation 32, 179-187, 2012 | 31 | 2012 |
| Phase I study to assess the safety, tolerability and pharmacokinetics of AZD4877 in Japanese patients with solid tumors T Esaki, T Seto, H Ariyama, S Arita, C Fujimoto, K Tsukasa, T Kometani, ... Archives of drug information 4 (2), 23-31, 2011 | 25 | 2011 |
| Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells J Cummings, R Sloane, K Morris, C Zhou, M Lancashire, D Moore, T Elliot, ... BMC cancer 14, 1-8, 2014 | 14 | 2014 |
| Assessment of diurnal changes and confounding factors that affect circulating cell death biomarker levels: a short communication A Greystoke, G Harris, M Jenkins, D Goonetilleke, D Moore, M Lancashire, ... Journal of pharmaceutical and biomedical analysis 84, 184-188, 2013 | 9 | 2013 |
| Assessment of the variability of and effect of hormone therapy on circulating tumor cell numbers and androgen receptor expression in patients with prostate cancer. NW Clarke, SE Marley, AM Hughes, AF Nash, MD Malone, JW Growcott, ... Journal of Clinical Oncology 30 (15_suppl), e15141-e15141, 2012 | | 2012 |
| A Cell Cycle-Specific Requirement for the XRCC1 BRCT II Domain During Mammalian DNA Strand Break Repair KWC RM Taylor, DJ Moore, J Whitehouse, P Johnson University of Manchester, 2000 | | 2000 |
Caroline DiveProfessor of Pharmacology, University of ManchesterVerified email at cruk.manchester.ac.uk
